Clinical chemistry in women treated with levonorgestrel implants (Norplant) or a TCu 200 IUD

Contraception
H B CroxattoM Pavez

Abstract

Two groups of implant users and two groups of IUD users participated in the study at different times. In the first groups, fractionation of lipoproteins was performed on serum samples from 28 subjects who had used the implants for 37 months and from 26 subjects who had used the Copper TCu 200 for 30 months. Users of the implants had significantly lower levels of total cholesterol, triglycerides and LDL-cholesterol than users of the IUDs. HDL-cholesterol levels were not different between the groups. In the other groups of women, general chemistries and selected hormone assays were carried out on samples from 30 subjects who had used implants for 51 months and from 24 subjects who had used the TCu 200 IUDs for 43 months. The parameters studied were the SM-12 chemistry group profile, estradiol, cortisol, testosterone, triiodothyronine, thyroxine and thyroid stimulating hormone. In the implant group, mean serum glucose levels were statistically significantly elevated and inorganic phosphorus levels were significantly reduced as compared to the IUD group. In both cases all individual measurements were within the normal range for the population. Testosterone and triiodothyronine levels in the implant group were significantly lower th...Continue Reading

Citations

Mar 1, 1990·Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception·K SinghS S Ratnam
Jun 1, 1992·Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception·S ThapaA Abeykoon
Dec 1, 1989·Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception·K SinghS S Ratnam
Jun 1, 1995·Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception·N P Noerpramana
Jul 1, 1996·Journal of Nurse-midwifery·J Womack, M W Beal
Feb 28, 2002·Contraception·Laneta J Dorflinger
Apr 29, 1998·Contraception·I S FraserI Sivin
Mar 7, 2002·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·S BassolR Recio
Aug 1, 1991·The Australian & New Zealand Journal of Obstetrics & Gynaecology·M Cooper
May 1, 1994·American Journal of Obstetrics and Gynecology·P D Darney
Jan 1, 1992·American Journal of Obstetrics and Gynecology·J C KonjeO A Ladipo
Aug 1, 1986·Contraception·S E OlssonE Johansson
Apr 1, 1993·Annals of Medicine·H B Croxatto
Jan 1, 1997·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·C RattrayH H Wynter
Sep 23, 2008·Expert Review of Medical Devices·Giuseppe BenagianoManuela Farris
Apr 13, 2007·Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP·Rainie L Sharpe, Deborah L MacLatchy

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.